Sinofn Health
Sinofn Health
Decoding the shift from general supplements to medically-supervised precision nutrition.
Foods for Special Medical Purposes (FSMP) represent the pinnacle of nutritional science. As global aging populations and chronic metabolic diseases rise, the demand for precision clinical nutrition has transitioned from hospital-only use to a major commercial sector. Leading manufacturers now focus on disease-specific formulas that require stringent pharmaceutical-grade compliance.
Unlike standard nutraceuticals, FSMP production requires "Information Gain" through clinical validation. Modern factories must integrate bioactive compound delivery systems with metabolic pathways research. This is where SINOFN excels, bridging the gap between molecular biology and food technology.
In a post-pandemic world, China's FSMP supply chain offers unparalleled efficiency. From raw material synthesis to high-speed encapsulation, the vertical integration of Chinese factories provides global brands with the agility to respond to market shifts while maintaining rigorous quality control through blockchain batch tracking.
SINOFN Health Co., Ltd. is the dedicated supplement OEM manufacturing division of SINOFN Group – a national high-tech enterprise founded in 2012 and backed by the Chinese Academy of Sciences. Established in 2025, we operate from Shanghai as the trading hub for global partners seeking premium, science-driven contract manufacturing services.
"We measure success not just in revenue, but in lives improved through accessible science." – Mrs. GuoHong Liu, Founder.
During her clinical work, Mrs. Liu witnessed lifelong struggles of PKU (Phenylketonuria) children. Driven to bridge this gap, she founded SINOFN to develop affordable, science-backed PKU foods. Today, her vision has expanded into clinical nutrition, functional foods, and global nutraceutical logistics.
Harnessing the expertise of the Chinese Academy of Sciences and international experts.
Medical Innovation Director
Ph.D. Peking University Medical School. 15+ years in metabolic disorder formulations and therapeutic nutrition.
R&D Lead
Associate Researcher, CAS Postdoc. Specialist in bioactive compound delivery systems and bioavailability enhancement.
Formulation Director
Senior Scientist (Netherlands). EU regulatory specialist in nutraceutical delivery technologies and EU-FSMP compliance.
Our commitment to "Information Gain" involves three primary pillars:
World-class facilities meeting ISO, HACCP, and FSSC certifications.
10+ dedicated lines for softgels, gummies, and powders. Annual capacity exceeds 500M+ units with real-time quality monitoring.
Equipped with HPLC/GC-MS for contaminant screening, microbiological safety testing, and stability/dissolution validation.
In-house pilot-scale prototyping for tablets, capsules, and liquids. Dedicated chambers for long-term stability testing.
Blockchain batch tracking from raw material storage to final packaging, ensuring 100% traceability for medical compliance.
Entering the FSMP market requires navigating complex regulatory landscapes. SINOFN provides a comprehensive "Compliance-as-a-Service" model:
SINOFN prioritizes intellectual property, holding 36 patents (11 invention, 12 utility model, 11 software copyrights, 2 design) and 71 multi-category trademarks. We are certified with ISO9001, ISO22000, HACCP, and HALAL, demonstrating our commitment to quality and safety.
